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Abstract
Background: Alveolar epithelial cells are known as progenitor cells for the restoration from the damage
in the lung. Calcitonin gene-related peptide (CGRP) has been reported to play an important role in the
proliferation of various types of epithelial and endothelial cells. We investigated the effects of CGRP on
the proliferation of alveolar epithelial cells in vitro and in vivo.
Methods: A549 cells were cultured in Dulbecco Modified Eagle Medium with 5% fatal bovin serum for 24
hours, then CGRP was added in vitro. The proliferation of DNA synthesis was measured using 5-bromo-
2-deoxyuridine, an analog of thymidine, by enzyme-linked immunosorbent assay.
As one intracellular response to CGRP, we examined activation of p44/42- extracellular signal-regulated
kinase (ERK) pathway by adding CGRP, using western blotting method.
Recombinant adenovirus encoding nuclear-targeted-human β-CGRP (rhCGRP) was administered into
M a l e  W i s t e r  r a t  ( n  =  5 ,  1 0  w e e k s  o l d )  lungs by intratracheal instillation in vivo. 7 days after the
administration of CGRP, rat lungs were harvested and histological findings and immunohistochemical
staining of proliferating cell nuclear antigen (PCNA) were evaluated to examine cell proliferation.
Results: In vitro study, CGRP increased the proliferation of A549 cells in a dose and time dependent
manner. CGRP8-37 (inhibitor of CGRP receptor) decreased CGRP induced proliferation of DNA
synthesis. Phosphorylation of ERK pathway was observed within 15 minutes and peaked in one hour.
U0126 (inhibitor of ERK pathway) decreased CGRP induced proliferation of DNA synthesis.In vivo study,
histological examination of the lung indicated proliferation of alveolar epithelial cells in the rhCGRP-
treated group and the nuclei of alveolar epithelial cells were positive for PCNA immunostaining.
Conclusion: In this study, we conclude that CGRP stimulates proliferation of human alveolar epithelial
cells in vivo and in vitro.
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Background
Organisms innately possess the ability to promptly repair
the injury inflicted upon the individual as one of the
defence mechanisms so that they can maintain the nor-
mal functions and structures of tissues and organs. After
lung injury, alveolar epithelial type II cells are known as
progenitor cells in the lung to regenerate and restore the
damage. Accordingly, it is hypothesized that factors which
facilitate proliferation of these cells would contribute to
the enhancement of lung regeneration and furthermore
may lead to treatment option.
Calcitonin gene-related peptide (CGRP) is 37-amino acid
neuropeptide found among neuroendocrine cells, sensory
C fibers, blood vesssels and lymphoid tissues in the nor-
mal lung [1,2]. In addition to the function of vasodilata-
tion [3], bronchial protection [4], regulatory function of
macrophages [5] and regulation of airway responsiveness
[6], CGRP has been reported to play a role in proliferation
of epithelial and endothelial cells of various types, such as
human endothelial cells [7], tracheal epithelial cells [8,9],
retinal pigment epithelial cells [10] and thymic epithelial
cells [11].
Meanwhile, it has been reported that pulmonary neuroen-
docrine cells and neuroendocrine bodies become neu-
roendocrine cell hyperplasia during the restoration
process, and these cells produce CGRP and have paracrine
effect on cell proliferation in the lung microenvironment
in airway and alveolar epithelial injury animal models
[12]. We have reported that relation between inflamma-
tion or fibrosis and CGRP expression in the animal mod-
els exposed to dusts of various types [13]. In the models
of lung injury induced by crystalline silica, crocidolite
asbestos and bleomycin, pathological findings of lung
inflammation increased progressively in a time depend-
ent manner, while low levels of CGRP concentration in
lungs were observed [13]. On the other hand, in lung
injury induced by exposure to silicon carbide whisker and
potassium octatitanate whisker, strong inflammation was
transient, then lung inflammation abated gradually, while
high levels of CGRP concentration in the lung were
observed at an early phase [13]. These findings suggest
that CGRP is involved in the lung restoration. Moreover,
it has been reported that ablation of the CGRP-releasing
sensory neurons aggravates severe inflammation, and
absence of CGRP intensifies the inflammatory reaction of
tissues induced by reperfusion in the CGRP-knockout
mice [14]. It is therefore thought that CGRP and sensory
neurons play an important role in maintaining the tissue
integrity by regulating local inflammatory responses in
the lung.
The extracellular signal-regulated kinase (ERK) pathway is
a critical pathway involved in the proliferation of many
cell types including alveolar epithelial cells.
On the basis of our hypothesis that CGRP proliferates
alveolar epithelial cells, we have examined the effects of
CGRP on the proliferation of alveolar epithelial cells and
ERK signalling pathway as one of the cell proliferation
pathways in vitro and in vivo.
Methods
Cell culture
A549 cells (RIKEN gene bank, Japan), originally derived
from human lung carcinoma were cultured in Dulbecco
Modified Eagle Medium (GIBCO Invitrogen, Japan) with
5% fatal bovin serum (FBS) (Biosource, Japan) containing
0.1% penicillin/streptomycin (Nakarai, Japan) in a
humidified incubator with 5% CO2 at 37°C. Cell cultures
were passaged at confluency approximately every three
days. Cells were then removed from monolayer culture in
trypsin containing ethylinedimine tetraacetic acid,
counted with a hemocytometer and plated in each well.
After incubating at 37°C for 24 hours, the cells were
washed with phosphate buffered saline (PBS) and then
cultured with Human CGRP (PEPTIDE INSTITUTE,
Japan) at variable concentrations for different time peri-
ods.
Cell proliferation analysis
In order to evaluate the effect of CGRP on proliferation of
A549 cells, DNA of proliferating cells were measured by
colorimetric 5-bromo-2-deoxyuridine (BrdU) Cell Prolif-
eration ELISA Kit (Roche, Japan). A549 cells were plated
in 96-well dishes (32 mm2/well, 6.0 × 103 cells/well) with
a medium volume of 100 μl/well. After 24 hours of incu-
bation, the cells were treated with 100 μl of 10-13 to 10-8 M
CGRP and incubated for 12, 24 and 36 hours. The cells
were reincubated for additional 2 hours at 37°C by add-
ing BrdU labelling solution (10 μl/well, final concentra-
tion: 10 μM), after which the labelling medium was
drained. The cells were dried with a hair-dryer for about
15 minutes and stored at 4°C for a few days. FixDenat
solution (200 μl/well) was added into each well and incu-
bated for 30 minutes at room temperature. FixDenat solu-
tion was immediately and thoroughly drained and anti-
BrdU-peroxidase working solution (100 μl/well) was
added and incubated for 30 minutes at room temperature.
Antibody conjugate was immediately removed and the
wells were rinsed three times with washing solution (200–
300 μl/well). Substrate solution (100 μl/ml) was added
and incubated at room temperature for about 5 minutes
until the colour development is sufficient for photometric
detection. Absorbance was measured using an automatic
enzyme-linked immunosorbent assay (ELISA) reader
(570 nm). The data was shown as a percentage for the
control.
In order to examine the influence of CGRP receptor and
ERK pathway, proliferation of A549 cells was measured by
the same method 24 hours after adding CGRP (10-10 M)Respiratory Research 2009, 10:8 http://respiratory-research.com/content/10/1/8
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and each inhibitor, U0126 (1 μM, inhibitor of ERK path-
way, Promega, USA) and CGRP8-37 (10-8 M, CGRP-recep-
tor antagonist, Sigma Chemical Co., USA).
Measurement of ERK phosphorylation (Western blot 
analysis)
A549 cells were plated in 6-well dishes (962 mm2/well,
1.5 × 105 cells/well) with a medium volume of 2 ml/well.
After adding CGRP, the cells were incubated for 24 hours.
Cell pellets were collected and membrane protein was iso-
lated by using ReadyPrep Protein Extraction Kit (Biorad,
USA). Protein levels were determined using the RC-DC
Assay Kit (Biorad). Aliquots of 20–30 μg protein were
boiled in loading buffer (New England Biolabs, USA) for
2 minutes, then loaded onto 12% Tris-glycine-polyacryla-
mide gel (Cambrex, USA) and transferred electrophoreti-
cally to nitrocellulose membranes.
40 μg of cell homogenate protein were added to gel load-
ing buffer (final concentration: 50 mM Tris, 70 mM NaCl,
1% sodium lauryl sulfate (SDS), 5% 2-mercaptoethanol)
and electrophoresed on polyacrylamide gel (15%) in the
presence of 0.1% SDS by using the Mini Protein 3 Dlectro-
phoresis System (Bio-Rad). The samples were electropho-
retically blotted on polyvinylidine difloride membrane
(ECL Western Blotting Detection System, Amersham Bio-
sciences, USA) at 25V for one hour by transblot apparatus.
Subsequently, the samples were incubated with 3% milk-
Tris-buffered saline-Tween 20 for one hour, after which
they were incubated at room temperature overnight with
rabbit anti-human p42/44 ERK and phospho- p42/44
ERK antibody (dilution 1/1,000, Cell Signalling Technol-
ogy Inc., Japan) in 3% milk-Tris-buffered saline-Tween
20. After three times of washing, the membrane was incu-
bated with peroxidase-conjugated sheep anti-rabbit IgG
(Amersham Biosciences) (dilution 1/5,000) for one hour.
The membrane was then washed three times, and the sig-
nals were finally visualized using the enhanced chemilu-
minescence system (Amersham Biosciences). The bands
of p42/44 ERK and phospho- p42/44 ERK were analyzed
with the National Institutes of Health Image 1.56 software
(written by Wane Rasband at NIH, Bethesda, USA).
Recombinant human CGRP (rhCGRP) Treatment
Recombinant adenovirus encoding nuclear-targeted-
human β-CGRP was generated using Adeno-X Expression
System 1 (Clontech Laboratories, USA). First, a mamma-
lian expression cassette was made by cloning human β-
CGRP gene (ResGen, USA) into pShuttle2. After amplifi-
cation in E. coli, the expression cassette was excised from
pShuttle2 and ligated to Adeno-X Viral DNA (the adeno-
viral genome). Because pShuttle2 and Adeno-X Viral DNA
carried different antibiotic selection markers, we did not
purify the expression cassette fragment for ligation with
Adeno-X. In the final stage, the recombinant Adeno-X vec-
tor was packaged into infectious adenovirus by transfect-
ing human embryonic kidney 293 cells. Recombinant
adenovirus was harvested by lysing transfected cells.
Recombinant adenoviruses titer was determined by Titer
Kit (Clontech Laboratories). Purified viruses were stored
in PBS and kept at -80°C until use.
In vivo analysis
The rats were handled according to the guidelines
described in the Japanese Guide for the Care and Use of
Laboratory Animals as approved by the University of
Occupational and Environmental Health Animal Care
and Use Committee. Male Wister rats (n = 5, 10 weeks old,
mean body weight 256 ± 20 g) were purchased from
Kyudo (Kumamoto, Japan). They were anesthetized with
inhaled ether in the box, and treated by intratracheal
injection of rhCGRP (4.0 × 108 infectious unit) or saline
through a cannula using a laryngoscope. They were
assigned to a rhCGRP group (n = 5) and a saline control
group (n = 5) for each exposure category and maintained
for 7 days after the injection. Each rat was then sacrificed
with a fatal over dosage of Nembutal (Dainippon Sumi-
tomo Pharma, Japan) intraperitoneally. After severing the
abdominal aorta, both lungs were removed and fixed by
intratracheal instillation of 4% paraformaldehyde
(MERCK, Japan) at 25 cmH2O pressure. The lung and tra-
chea were excised from the surrounding tissue and
allowed to stand at 4°C for 24 hours. The tissue was
washed for 10 minutes in PBS, dehydrated by immersing
in a graded series of one hour ethanol washes, before
being finally maintained in 100% ethanol at 4°C. The
lung tissue was embedded in paraffin and cut into each 5
μm section, and Hematoxylin-Eosin (HE) staining and
immunohistochemical staining for proliferating cell
nuclear antigen (PCNA) (Dako, Denmark) were per-
formed.
For PCNA immunohistochemistry, the tissue sections
were air-dried, and deparaffinized by washing in xylene
for 3 minutes four times, followed by dehydration
through a series of 100% to 70% ethanol washes. The
slides were placed in methanol containing 0.3% hydrogen
peroxide to block endogenous peroxidase activity. Non-
specific binding was blocked by incubating with 10% goat
serum for 10 minutes at room temperature. Then the lung
sections were incubated overnight at 4°C with mono-
clonal mouse antibody specific for PCNA (diluted 1:500–
1:1000 before use). The sections were rinsed three times
in 0.1 M PBS and incubated for 30 minutes at room tem-
perature with biotinylated anti-mouse secondary anti-
body, then incubated with avidin-biotin complex (DAKORespiratory Research 2009, 10:8 http://respiratory-research.com/content/10/1/8
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JAPAN, Japan) for 30 minutes at room temperature. Sec-
tions were washed with PBS and incubated with diami-
nobenzidine for 7 minutes, and counterstained with
hematoxylin. Tissue incubations without the primary or
secondary antibody were carried out as labeling controls.
Statistical analysis
Values were expressed as mean ± one standard deviation.
We used non-parametric Mann-Whitney U test for the sta-
tistical analysis with two groups. Statistical significance
was analyzed using analysis of variance. A probability (p)
value less than 0.05 was considered significant.
Results
Cell proliferation by CGRP in vitro
CGRP (10-11-10-8  M) significantly increased the BrdU
incorporation in A549 cells in a dose dependent manner
(Fig. 1A). Similar tendency was observed at 12, 24 and 36
hours after the exposure. CGRP-induced increase of BrdU
incorporation was also observed in a time dependent
manner (Fig. 1B).
Compared to the group treated with CGRP only, pread-
ministration of CGRP-receptor antagonist (CGRP 8–37)
significantly inhibited the increase of BrdU incorporation
(Fig. 2).
ERK phosphorylation in vitro
p42/44-ERK protein was phosphorylated with tyrosine
and threonine within 15 minutes, and the phosphoryla-
tion maintained its maximal effects for one hour (Fig. 3).
These data suggest that CGRP stimulates the proliferation
of human alveolar epithelial cells via ERK pathway.
Compared to the group with CGRP only, addition of
CGRP and ERK inhibitor (U0126) significantly inhibited
the increase of BrdU incorporation (Fig. 4).
Effect of recombinant human CGRP vector in rat lung
Proliferation of alveolar epithelial cells and interstitial
thickening were observed in the rhCGRP-exposed group
BrdU incorporation induced by CGRP on A549 cells Figure 1
BrdU incorporation induced by CGRP on A549 cells. 
CGRP increased BrdU incorporation in a dose dependent 
manner (A) and a time dependent manner (B). Cells were 
prepared as described in Methods. Data represents the 
means ± SEM of five experiments. *: p < 0.05 compared to 
control **: p < 0.01 compared to control.
Inhibition of BrdU incorporation induced by CGRP receptor  antagonist Figure 2
Inhibition of BrdU incorporation induced by CGRP 
receptor antagonist. CGRP8-37 (inhibitor of CGRP 
receptor, 10-8 M) decreased CGRP-induced proliferation. *: P 
< 0.05 compared to control †: p < 0.05 compared to only 
CGRP 10-10 M.
Western blotting of p44/42- extracellular signal-regulated  kinase Figure 3
Western blotting of p44/42- extracellular signal-regu-
lated kinase. Activation of p44/42-ERK pathway by adding 
CGRP occurred within 15 minutes and peaked in one hour.
p44/42 ERK
Phospho-
p44/42 ERK
control 15min 1h 2h 6h
5min 30min 1.5h 3h          18h
20
15
10
5
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compared with the control group (Fig. 5). Similarly, pro-
liferation of bronchial epithelial cells was observed while
mild interstitial infiltration of lymphocytes was also
observed. Immunostaining for PCNA was observed in the
nuclei of alveolar epithelial cells (Fig. 6).
Discussion
In this study, we observed that CGRP facilitates prolifera-
tion of A549 cells via CGRP receptor and ERK pathway in
vitro.
Regarding the proliferative effects of CGRP on various epi-
thelial and endothelial cells, CGRP has been reported to
proliferate human endothelial cells [7], airway epithelial
cells [8,9] retinal pigment epithelial cells [10], thymic epi-
thelial cells [11]. On the other hand, no such effects have
been indicated on lung fibroblast cells [15] and inhibitory
function has been found on vascular smooth muscle cells
[16].
In the present study, 10 pM-10 nM CGRP significantly
increased A549 cell proliferation. Other studies con-
ducted with guinea pig tracheal epithelial cells, retinal pig-
ment epithelial cell or rat thymic epithelial cells, 1 pM-1
μM CGRP have also showed cell proliferation, and our
data fell within this range [7-11]. CGRP concentration in
the rat lung was 18.5 nM, and the exposure level of the
concentration in this study was considered as physiologi-
cal.
It has also been reported that growth factors, such as epi-
dermal growth factor, hepatocyte growth factor (HGF)
and keratinocyte growth factor (KGF) have proliferative
effect on alveolar epithelial cells [17-19]. According to
these previous reports, HGF increases thymidine incorpo-
ration 3.4 times as much, compared to the control group
[17], whereas recombinant adenovirus vector expressing
KGF (Ad5-KGF) increases thymidine incorporation in a
dose dependent manner [18]. In our experiment, effect of
CGRP was as minor as approximately 1.2 to 1.3 times
compared to other growth factors. In comparative studies
on the effects of HGF and KGF, KGF seemed to have larger
proliferative effect on alveolar epithelial cells in vitro but
the contrary effects were observed in vivo [20,21]. As is
suggested by these results, comparison between prolifera-
tion of alveolar epithelial cells in vivo and in vitro cannot
be generalized.
In the present in vivo experiment, proliferation of alveolar
epithelial cells was actually observed in the rat lung in
which CGRP expression was artificially created. It was
reported that proliferation of alveolar epithelial cells
peaked two days after the exposure of HGF intratracheally
in the rat lung [22]. Meanwhile, hyperplasia of alveolar
epithelial cells reportedly occurred in the early phase (2–
7 days after the exposure) in the rat lungs dissected 2–28
days after KGF intratracheal injection [18]. The finding of
alveolar epithelial cell proliferation on the seventh day
after the CGRP exposure is similar to other growth factors.
The result that preadministration of CGRP receptor inhib-
itor restrained increase of alveolar epithelial cell prolifera-
tion by CGRP seems to be supported by the previous
findings that CGRP was produced by the paracrine effect
in the lung microenvironment, resulting in proliferation
of airway and alveolar epithelial cells [12] and that CGRP
receptors were found in the membrane of A549 cells [23].
Generally, CGRP in the normal lung is secreted from neu-
roendocrine cells existing in the central airways [24], and
there are several reports indicating that CGRP is secreted
from A549 cells [23,25]. In these reports, CGRP secretion
from A549 cells increased under the condition of hypoxia,
and they also suggested that distribution of CGRP secre-
tion would be different under stressful situations.
Inhibition of BrdU incorporation induced by ERK inhibitor Figure 4
Inhibition of BrdU incorporation induced by ERK 
inhibitor. U0126 (inhibitor of ERK pathway, 10-6 M) 
decreased the CGRP-induced proliferation. *: p < 0.05 com-
pared to control †: p < 0.01 compared to only CGRP10-10 M.Respiratory Research 2009, 10:8 http://respiratory-research.com/content/10/1/8
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We also observed ERK phosphorylation during CGRP
induced cell proliferation. The ERK pathway is a critical
pathway involved in the proliferation of many cell types,
and proliferation of alveolar epithelial cells induced by
ERK activation has been reported [26]. Our result showed
that ERK activation peaked between 5 minutes and one
hour after the exposure of CGRP and continued for at least
18 hours. In studies with KGF which proliferates alveolar
epithelial cells, ERK activation appeared after 5 minutes
and lasted for 90 minutes [27]. Such result showed similar
tendency to the findings in this study.
Harada et al. reported that CGRP increased insulin-like
growth factor-1 (IGF-1) production [28], so we also exam-
ined pulmonary immunohistochemical staining of IGF-1
in this study. No significantly immunostained for IGF-1
cells were observed in the lung in CGRP exposed group,
and IGF-1 levels in culture medium of A549 cells after
exposure to CGRP did not increase. Therefore we think
that IGF-1 induced by CGRP may be minimal in the rat
lung.
Recent reports suggest that growth factors, such as HGF
and KGF, proliferate alveolar epithelial cells while they
inhibit lung injury. Increased function of cell proliferation
in vivo and in vitro is thought to be involved with lung res-
toration. We would like to hereafter examine the effects of
CGRP preadministration in various types of lung injury
models.
In conclusion, this study describes the proliferative effects
of CGRP on A549 cells in a dose dependent and time
dependent manner in vitro, via CGRP receptor and ERK
pathway. Proliferation of alveolar epithelial cells and
interstitial thickening were also observed in CGRP
exposed rat lung in vivo, and we speculate that CGRP has
proliferatory function on alveolar epithelial cells.
Histopathology of CGRP treated rat lung Figure 5
Histopathology of CGRP treated rat lung. Recombinant human CGRP (rhCGRP) were administered into Wister rat lung 
by intratracheal instillation. Proliferation of alveolar epithelial cells and interstitial thickening were observed in the rhCGRP-
exposed group (B, C) compared with those in the control group (A) 7 days after CGRP exposure. The bars represent 200 μm.
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